Private Equity

Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.



Sign up for a 7-day FREE trial today!



Latest News in Private Equity

  • September 28, 2026

    Cannabis Distributor Says Partner Denied Its $332K Stake

    The manager of a Los Angeles cannabis cultivation facility seized an entire harvest without his business partner's permission, selling much of it until armed men raided the facility and took a significant portion of the inventory, according to a state lawsuit seeking more than $300,000 for the iced-out partner.

  • September 28, 2026

    3 Firms Lead $663.7M Lifecore Biomedical Take-Private Deal

    Lifecore Biomedical Inc. on Monday unveiled plans to become a private company after it is bought by private equity shop Webster Equity Partners in a deal valued at up to $663.7 million that was built by three law firms.

  • September 28, 2026

    Policyholders Say RICO Plot 'Pillaged' Insurer's Assets

    A private equity firm and a financial services business have been hit with civil racketeering claims by the holders of a combined $5 million in PHL Variable Insurance Co. policies, but whose benefits were capped at just $300,000 during a Connecticut state-managed rehabilitation effort.

  • September 28, 2026

    Nextdoor, Khosla Say Investor Brought De-SPAC Suit Too Late

    Nextdoor and Khosla Ventures urged the Delaware Chancery Court on Monday to dismiss a stockholder lawsuit challenging Nextdoor's de-SPAC merger as untimely, arguing the clock began running when the proxy that an investor described as misleading was issued in October 2021, while the plaintiff insisted later disclosures and tolling doctrines keep her claims alive.

  • September 28, 2026

    Lantheus Investor Asks Court To Halt 'Unfair' $8B Curium Deal

    A Lantheus Holdings Inc. investor wants a Massachusetts state judge to block its $8 billion take-private deal with fellow radiopharmaceutical company Curium in its current form, calling the deal "fundamentally unfair" to shareholders.

See more Private Equity news

Private Equity

Areas of Coverage

  • TRANSACTIONS
  • Private equity deals valued at $50MM or more
  • Venture capital investments of $25MM or more
  • Mergers and acquisitions
  • Capital investments, including mezzanine and growth capital deals
  • Joint ventures involving private equity firms
  • Hostile takeovers and leveraged buyouts
  • Distressed investment deals
  • AGENCIES
  • U.S. Commodity Futures Trading Commission
  • Federal Trade Commission
  • Financial Industry Regulatory Authority
  • Public Company Accounting Oversight Board
  • U.S. Department of Justice
  • U.S. Department of the Treasury
  • U.S. Securities and Exchange Commission
  • International competition and securities regulators
  • POLICY & REGULATION
  • Dodd-Frank Act
  • Delaware corporate law
  • Antitrust and consumer protection controls
  • Private equity industry lobbying
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • Litigation
  • Antitrust suits
  • Shareholder disputes
  • Corporate governance fights
  • Poison pill challenges
  • Hostile takeover disputes
  • Privacy and consumer protection suits
  • Bankruptcy proceedings involving private equity stakeholders
  • PROFILES
  • Personnel moves
  • Profiles of private equity practices

Readership

  • Private equity lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the private equity industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals